Kurs & Likviditet
Beskrivning
Land | Danmark |
---|---|
Lista | First North Denmark |
Sektor | Hälsovård |
Industri | Medicinteknik |
12.10.2023 08:09:54 CEST | BactiQuant A/S | Periodeoplysning
BactiQuant havde et godt 1. til 3. kvartal i 2023 med 18% vækst i omsætningen ift. samme periode i 2022 båret af vækst i salg af Online udstyr og testkits, som udgør det strategiske vækstområde for BactiQuant. Der er en fortsat spændende udvikling på flere kundesegmenter.
BactiQuant udsender hermed trading statement Q3 2023. Kvartalsrapporteringen for Q3 2023 kan læses i sin helhed i det vedhæftede pdf-dokument.
Kontakter
- Henrik Enegaard Skaanderup, Bestyrelsesformand, +4540334470, henrik-skaanderup@mail.dk
- Morten Miller, Chief Executive Officer CEO/CINO, +4523678732, miller@bactiquant.dk
Om BactiQuant A/S
Bactiquant has developed a technology that will revolutionize the monitoring of bacterial contamination levels in water and ensure optimum usage and handling of water around the world to the benefit of our customers and the sustainability of our planet. To show our environmental commitment, we have aligned our business with four of the UN's Sustainable Development Goals. We believe that Bactiquant will be the world leader within mobile and online surveillance of bacterial contamination levels, and we are already well on our way. Headquartered in Denmark and operating across five continents, our customers come from a wide range of industries such as public water utility companies, industries needing water cooling or requiring wastewater treatment, and aquaculture.